Zdrowie i gospodarka · 04/06/1999

FDA Releases Draft Guidance for Reviewers on Evaluation of Human Pregnancy Outcome Data

The Food and Drug Administration (FDA) has released a draft guidance document for reviewers to evaluate human pregnancy outcome data related to maternal drug exposure. The document will be discussed during a meeting of the Subcommittee of the Advisory Committee for Reproductive Health Drugs on June 3, 1999.